ESTEBAN ONATE: Open Payments
NPI 1003898560 · UTICA, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,871 in 105 payments from 20 companies in 2025. Trend: 2023 $1,567 · 2024 $2,718 · 2025 $2,871
Food & beverage: $2,787Education: $84
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 30 | $714 |
| Janssen Biotech, Inc. | 19 | $560 |
| Madrigal Pharmaceuticals | 6 | $323 |
| Takeda Pharmaceuticals U.S.A., Inc. | 11 | $242 |
| QOL Medical, LLC | 3 | $183 |
| Lilly USA, LLC | 4 | $157 |
| Gilead Sciences, Inc. | 6 | $129 |
| PFIZER INC. | 6 | $113 |
| Aimmune Therapeutics, Inc. | 4 | $98 |
| Regeneron Healthcare Solutions, Inc. | 3 | $97 |
Products named: TREMFYA, RINVOQ, REZDIFFRA, Sucraid, SKYRIZI, ENTYVIO, DUPIXENT, CREON.
Industry payments across NY — which companies pay providers there.
